Global Salivary Gland Cancer Treatment Production, Demand and Key Producers, 2022-2028
Surgery (removing the cancer in an operation) is a common treatment for salivary gland cancer. A doctor may remove the cancer and some of the healthy tissue around the cancer. In some cases, a lymphadenectomy (surgery in which lymph nodes are removed) will also be done.
This report studies the global Salivary Gland Cancer Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Salivary Gland Cancer Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Salivary Gland Cancer Treatment that contribute to its increasing demand across many markets.
The global Salivary Gland Cancer Treatment market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Salivary Gland Cancer Treatment total market, 2017-2028, (USD Million)
Global Salivary Gland Cancer Treatment total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Salivary Gland Cancer Treatment total market, key domestic companies and share, (USD Million)
Global Salivary Gland Cancer Treatment revenue by player and market share 2017-2022, (USD Million)
Global Salivary Gland Cancer Treatment total market by Type, CAGR, 2017-2028, (USD Million)
Global Salivary Gland Cancer Treatment total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Salivary Gland Cancer Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb, LGM Pharma, LLC, Pfizer, Bedford Laboratories, Baxter, Sanofi-Aventis U.S. LLC, Pierre Fabre, Antares Pharma, Inc and CMS Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Salivary Gland Cancer Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Salivary Gland Cancer Treatment Market, By Region:
1. How big is the global Salivary Gland Cancer Treatment market?
2. What is the demand of the global Salivary Gland Cancer Treatment market?
3. What is the year over year growth of the global Salivary Gland Cancer Treatment market?
4. What is the total value of the global Salivary Gland Cancer Treatment market?
5. Who are the major players in the global Salivary Gland Cancer Treatment market?
6. What are the growth factors driving the market demand?
This report studies the global Salivary Gland Cancer Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Salivary Gland Cancer Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Salivary Gland Cancer Treatment that contribute to its increasing demand across many markets.
The global Salivary Gland Cancer Treatment market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Salivary Gland Cancer Treatment total market, 2017-2028, (USD Million)
Global Salivary Gland Cancer Treatment total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Salivary Gland Cancer Treatment total market, key domestic companies and share, (USD Million)
Global Salivary Gland Cancer Treatment revenue by player and market share 2017-2022, (USD Million)
Global Salivary Gland Cancer Treatment total market by Type, CAGR, 2017-2028, (USD Million)
Global Salivary Gland Cancer Treatment total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Salivary Gland Cancer Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol Myers Squibb, LGM Pharma, LLC, Pfizer, Bedford Laboratories, Baxter, Sanofi-Aventis U.S. LLC, Pierre Fabre, Antares Pharma, Inc and CMS Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Salivary Gland Cancer Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Salivary Gland Cancer Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Surgical Removal
- Radiation Therapy
- Drug Therapy
- Others
- Hospitals
- Clinics
- Outpatient Surgery Center
- Diagnostic Center
- Others
- Bristol Myers Squibb
- LGM Pharma, LLC
- Pfizer
- Bedford Laboratories
- Baxter
- Sanofi-Aventis U.S. LLC
- Pierre Fabre
- Antares Pharma, Inc
- CMS Group
- Sandoz Inc
1. How big is the global Salivary Gland Cancer Treatment market?
2. What is the demand of the global Salivary Gland Cancer Treatment market?
3. What is the year over year growth of the global Salivary Gland Cancer Treatment market?
4. What is the total value of the global Salivary Gland Cancer Treatment market?
5. Who are the major players in the global Salivary Gland Cancer Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Salivary Gland Cancer Treatment Introduction
1.2 World Salivary Gland Cancer Treatment Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Salivary Gland Cancer Treatment Total Market by Region
1.3.1 World Salivary Gland Cancer Treatment Market Size by Region (2017-2028)
1.3.2 United States Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.3 China Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.4 Europe Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.5 Japan Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.6 South Korea Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.7 ASEAN Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.8 India Salivary Gland Cancer Treatment Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Salivary Gland Cancer Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Salivary Gland Cancer Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD SALIVARY GLAND CANCER TREATMENT COMPANIES COMPETITIVE ANALYSIS
2.1 World Salivary Gland Cancer Treatment Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Salivary Gland Cancer Treatment Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Salivary Gland Cancer Treatment in 2021
2.2.3 Global Concentration Ratios (CR8) for Salivary Gland Cancer Treatment in 2021
2.3 Salivary Gland Cancer Treatment Company Evaluation Quadrant
2.4 Salivary Gland Cancer Treatment Market: Overall Company Footprint Analysis
2.4.1 Salivary Gland Cancer Treatment Market: Region Footprint
2.4.2 Salivary Gland Cancer Treatment Market: Company Product Type Footprint
2.4.3 Salivary Gland Cancer Treatment Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Salivary Gland Cancer Treatment Market Comparison
3.1.1 United States VS China: Salivary Gland Cancer Treatment Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Salivary Gland Cancer Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Salivary Gland Cancer Treatment Major Players and Market Share, 2017-2022
3.2.1 Major Players of Salivary Gland Cancer Treatment in United States, Headquarters (States, Country)
3.2.2 United States Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022)
3.3 China Salivary Gland Cancer Treatment Major Players and Market Share, 2017-2022
3.3.1 Major Players of Salivary Gland Cancer Treatment in China, Headquarters (Province, Country)
3.3.2 China Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Salivary Gland Cancer Treatment Major Players and Market Share, 2017-2022
3.4.1 Major Players of Salivary Gland Cancer Treatment in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Salivary Gland Cancer Treatment Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Surgical Removal
4.2.2 Radiation Therapy
4.2.3 Drug Therapy
4.2.4 Others
4.3 Market Segment by Type
4.3.1 World Salivary Gland Cancer Treatment Market Size by Type (2017-2022)
4.3.2 World Salivary Gland Cancer Treatment Market Size by Type (2023-2028)
4.3.3 World Salivary Gland Cancer Treatment Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Salivary Gland Cancer Treatment Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospitals
5.2.2 Clinics
5.2.3 Outpatient Surgery Center
5.2.4 Diagnostic Center
5.2.5 Diagnostic Center
5.3 Market Segment by Application
5.3.1 World Salivary Gland Cancer Treatment Market Size by Application (2017-2022)
5.3.2 World Salivary Gland Cancer Treatment Market Size by Application (2023-2028)
5.3.3 World Salivary Gland Cancer Treatment Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Details
6.1.2 Bristol Myers Squibb Major Business
6.1.3 Bristol Myers Squibb Salivary Gland Cancer Treatment Product and Services
6.1.4 Bristol Myers Squibb Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.1.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
6.2 LGM Pharma, LLC
6.2.1 LGM Pharma, LLC Details
6.2.2 LGM Pharma, LLC Major Business
6.2.3 LGM Pharma, LLC Salivary Gland Cancer Treatment Product and Services
6.2.4 LGM Pharma, LLC Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 LGM Pharma, LLC Recent Developments/Updates
6.2.6 LGM Pharma, LLC Competitive Strengths & Weaknesses
6.3 Pfizer
6.3.1 Pfizer Details
6.3.2 Pfizer Major Business
6.3.3 Pfizer Salivary Gland Cancer Treatment Product and Services
6.3.4 Pfizer Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Pfizer Recent Developments/Updates
6.3.6 Pfizer Competitive Strengths & Weaknesses
6.4 Bedford Laboratories
6.4.1 Bedford Laboratories Details
6.4.2 Bedford Laboratories Major Business
6.4.3 Bedford Laboratories Salivary Gland Cancer Treatment Product and Services
6.4.4 Bedford Laboratories Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Bedford Laboratories Recent Developments/Updates
6.4.6 Bedford Laboratories Competitive Strengths & Weaknesses
6.5 Baxter
6.5.1 Baxter Details
6.5.2 Baxter Major Business
6.5.3 Baxter Salivary Gland Cancer Treatment Product and Services
6.5.4 Baxter Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Baxter Recent Developments/Updates
6.5.6 Baxter Competitive Strengths & Weaknesses
6.6 Sanofi-Aventis U.S. LLC
6.6.1 Sanofi-Aventis U.S. LLC Details
6.6.2 Sanofi-Aventis U.S. LLC Major Business
6.6.3 Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Product and Services
6.6.4 Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Sanofi-Aventis U.S. LLC Recent Developments/Updates
6.6.6 Sanofi-Aventis U.S. LLC Competitive Strengths & Weaknesses
6.7 Pierre Fabre
6.7.1 Pierre Fabre Details
6.7.2 Pierre Fabre Major Business
6.7.3 Pierre Fabre Salivary Gland Cancer Treatment Product and Services
6.7.4 Pierre Fabre Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Pierre Fabre Recent Developments/Updates
6.7.6 Pierre Fabre Competitive Strengths & Weaknesses
6.8 Antares Pharma, Inc
6.8.1 Antares Pharma, Inc Details
6.8.2 Antares Pharma, Inc Major Business
6.8.3 Antares Pharma, Inc Salivary Gland Cancer Treatment Product and Services
6.8.4 Antares Pharma, Inc Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Antares Pharma, Inc Recent Developments/Updates
6.8.6 Antares Pharma, Inc Competitive Strengths & Weaknesses
6.9 CMS Group
6.9.1 CMS Group Details
6.9.2 CMS Group Major Business
6.9.3 CMS Group Salivary Gland Cancer Treatment Product and Services
6.9.4 CMS Group Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 CMS Group Recent Developments/Updates
6.9.6 CMS Group Competitive Strengths & Weaknesses
6.10 Sandoz Inc
6.10.1 Sandoz Inc Details
6.10.2 Sandoz Inc Major Business
6.10.3 Sandoz Inc Salivary Gland Cancer Treatment Product and Services
6.10.4 Sandoz Inc Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Sandoz Inc Recent Developments/Updates
6.10.6 Sandoz Inc Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Salivary Gland Cancer Treatment and Key Manufacturers
7.2 Salivary Gland Cancer Treatment Manufacturing Costs
7.3 Salivary Gland Cancer Treatment Production Process
7.4 Salivary Gland Cancer Treatment Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Salivary Gland Cancer Treatment Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Salivary Gland Cancer Treatment Typical Distributors
8.3 Salivary Gland Cancer Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Salivary Gland Cancer Treatment Introduction
1.2 World Salivary Gland Cancer Treatment Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Salivary Gland Cancer Treatment Total Market by Region
1.3.1 World Salivary Gland Cancer Treatment Market Size by Region (2017-2028)
1.3.2 United States Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.3 China Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.4 Europe Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.5 Japan Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.6 South Korea Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.7 ASEAN Salivary Gland Cancer Treatment Market Size (2017-2028)
1.3.8 India Salivary Gland Cancer Treatment Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Salivary Gland Cancer Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Salivary Gland Cancer Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD SALIVARY GLAND CANCER TREATMENT COMPANIES COMPETITIVE ANALYSIS
2.1 World Salivary Gland Cancer Treatment Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Salivary Gland Cancer Treatment Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Salivary Gland Cancer Treatment in 2021
2.2.3 Global Concentration Ratios (CR8) for Salivary Gland Cancer Treatment in 2021
2.3 Salivary Gland Cancer Treatment Company Evaluation Quadrant
2.4 Salivary Gland Cancer Treatment Market: Overall Company Footprint Analysis
2.4.1 Salivary Gland Cancer Treatment Market: Region Footprint
2.4.2 Salivary Gland Cancer Treatment Market: Company Product Type Footprint
2.4.3 Salivary Gland Cancer Treatment Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Salivary Gland Cancer Treatment Market Comparison
3.1.1 United States VS China: Salivary Gland Cancer Treatment Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Salivary Gland Cancer Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Salivary Gland Cancer Treatment Major Players and Market Share, 2017-2022
3.2.1 Major Players of Salivary Gland Cancer Treatment in United States, Headquarters (States, Country)
3.2.2 United States Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022)
3.3 China Salivary Gland Cancer Treatment Major Players and Market Share, 2017-2022
3.3.1 Major Players of Salivary Gland Cancer Treatment in China, Headquarters (Province, Country)
3.3.2 China Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Salivary Gland Cancer Treatment Major Players and Market Share, 2017-2022
3.4.1 Major Players of Salivary Gland Cancer Treatment in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Salivary Gland Cancer Treatment Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Surgical Removal
4.2.2 Radiation Therapy
4.2.3 Drug Therapy
4.2.4 Others
4.3 Market Segment by Type
4.3.1 World Salivary Gland Cancer Treatment Market Size by Type (2017-2022)
4.3.2 World Salivary Gland Cancer Treatment Market Size by Type (2023-2028)
4.3.3 World Salivary Gland Cancer Treatment Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Salivary Gland Cancer Treatment Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospitals
5.2.2 Clinics
5.2.3 Outpatient Surgery Center
5.2.4 Diagnostic Center
5.2.5 Diagnostic Center
5.3 Market Segment by Application
5.3.1 World Salivary Gland Cancer Treatment Market Size by Application (2017-2022)
5.3.2 World Salivary Gland Cancer Treatment Market Size by Application (2023-2028)
5.3.3 World Salivary Gland Cancer Treatment Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Details
6.1.2 Bristol Myers Squibb Major Business
6.1.3 Bristol Myers Squibb Salivary Gland Cancer Treatment Product and Services
6.1.4 Bristol Myers Squibb Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.1.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
6.2 LGM Pharma, LLC
6.2.1 LGM Pharma, LLC Details
6.2.2 LGM Pharma, LLC Major Business
6.2.3 LGM Pharma, LLC Salivary Gland Cancer Treatment Product and Services
6.2.4 LGM Pharma, LLC Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 LGM Pharma, LLC Recent Developments/Updates
6.2.6 LGM Pharma, LLC Competitive Strengths & Weaknesses
6.3 Pfizer
6.3.1 Pfizer Details
6.3.2 Pfizer Major Business
6.3.3 Pfizer Salivary Gland Cancer Treatment Product and Services
6.3.4 Pfizer Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Pfizer Recent Developments/Updates
6.3.6 Pfizer Competitive Strengths & Weaknesses
6.4 Bedford Laboratories
6.4.1 Bedford Laboratories Details
6.4.2 Bedford Laboratories Major Business
6.4.3 Bedford Laboratories Salivary Gland Cancer Treatment Product and Services
6.4.4 Bedford Laboratories Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Bedford Laboratories Recent Developments/Updates
6.4.6 Bedford Laboratories Competitive Strengths & Weaknesses
6.5 Baxter
6.5.1 Baxter Details
6.5.2 Baxter Major Business
6.5.3 Baxter Salivary Gland Cancer Treatment Product and Services
6.5.4 Baxter Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Baxter Recent Developments/Updates
6.5.6 Baxter Competitive Strengths & Weaknesses
6.6 Sanofi-Aventis U.S. LLC
6.6.1 Sanofi-Aventis U.S. LLC Details
6.6.2 Sanofi-Aventis U.S. LLC Major Business
6.6.3 Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Product and Services
6.6.4 Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Sanofi-Aventis U.S. LLC Recent Developments/Updates
6.6.6 Sanofi-Aventis U.S. LLC Competitive Strengths & Weaknesses
6.7 Pierre Fabre
6.7.1 Pierre Fabre Details
6.7.2 Pierre Fabre Major Business
6.7.3 Pierre Fabre Salivary Gland Cancer Treatment Product and Services
6.7.4 Pierre Fabre Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Pierre Fabre Recent Developments/Updates
6.7.6 Pierre Fabre Competitive Strengths & Weaknesses
6.8 Antares Pharma, Inc
6.8.1 Antares Pharma, Inc Details
6.8.2 Antares Pharma, Inc Major Business
6.8.3 Antares Pharma, Inc Salivary Gland Cancer Treatment Product and Services
6.8.4 Antares Pharma, Inc Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Antares Pharma, Inc Recent Developments/Updates
6.8.6 Antares Pharma, Inc Competitive Strengths & Weaknesses
6.9 CMS Group
6.9.1 CMS Group Details
6.9.2 CMS Group Major Business
6.9.3 CMS Group Salivary Gland Cancer Treatment Product and Services
6.9.4 CMS Group Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 CMS Group Recent Developments/Updates
6.9.6 CMS Group Competitive Strengths & Weaknesses
6.10 Sandoz Inc
6.10.1 Sandoz Inc Details
6.10.2 Sandoz Inc Major Business
6.10.3 Sandoz Inc Salivary Gland Cancer Treatment Product and Services
6.10.4 Sandoz Inc Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Sandoz Inc Recent Developments/Updates
6.10.6 Sandoz Inc Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Salivary Gland Cancer Treatment and Key Manufacturers
7.2 Salivary Gland Cancer Treatment Manufacturing Costs
7.3 Salivary Gland Cancer Treatment Production Process
7.4 Salivary Gland Cancer Treatment Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Salivary Gland Cancer Treatment Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Salivary Gland Cancer Treatment Typical Distributors
8.3 Salivary Gland Cancer Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Salivary Gland Cancer Treatment Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Salivary Gland Cancer Treatment Market Size by Region (2017-2022) & (USD Million)
Table 3. World Salivary Gland Cancer Treatment Market Size by Region (2023-2028) & (USD Million)
Table 4. World Salivary Gland Cancer Treatment Market Size Market Share by Region (2017-2022)
Table 5. World Salivary Gland Cancer Treatment Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Salivary Gland Cancer Treatment Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Salivary Gland Cancer Treatment Players in 2021
Table 9. World Salivary Gland Cancer Treatment Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Salivary Gland Cancer Treatment Company Evaluation Quadrant
Table 11. Head Office of Key Salivary Gland Cancer Treatment Player
Table 12. Salivary Gland Cancer Treatment Market: Company Product Type Footprint
Table 13. Salivary Gland Cancer Treatment Market: Company Product Application Footprint
Table 14. Salivary Gland Cancer Treatment Mergers & Acquisitions Activity
Table 15. United States VS China Salivary Gland Cancer Treatment Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Salivary Gland Cancer Treatment in United States, Headquarters (States, Country)
Table 17. United States Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Salivary Gland Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Salivary Gland Cancer Treatment in China, Company Headquarters (Province, Country)
Table 20. China Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Salivary Gland Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Salivary Gland Cancer Treatment in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Salivary Gland Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Salivary Gland Cancer Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Salivary Gland Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 27. World Salivary Gland Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 28. World Salivary Gland Cancer Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Salivary Gland Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 30. World Salivary Gland Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 31. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 32. Bristol Myers Squibb Major Business
Table 33. Bristol Myers Squibb Salivary Gland Cancer Treatment Product and Services
Table 34. Bristol Myers Squibb Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Bristol Myers Squibb Recent Developments/Updates
Table 36. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 37. LGM Pharma, LLC Basic Information, Area Served and Competitors
Table 38. LGM Pharma, LLC Major Business
Table 39. LGM Pharma, LLC Salivary Gland Cancer Treatment Product and Services
Table 40. LGM Pharma, LLC Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. LGM Pharma, LLC Recent Developments/Updates
Table 42. LGM Pharma, LLC Competitive Strengths & Weaknesses
Table 43. Pfizer Basic Information, Area Served and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Salivary Gland Cancer Treatment Product and Services
Table 46. Pfizer Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Pfizer Recent Developments/Updates
Table 48. Pfizer Competitive Strengths & Weaknesses
Table 49. Bedford Laboratories Basic Information, Area Served and Competitors
Table 50. Bedford Laboratories Major Business
Table 51. Bedford Laboratories Salivary Gland Cancer Treatment Product and Services
Table 52. Bedford Laboratories Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Bedford Laboratories Recent Developments/Updates
Table 54. Bedford Laboratories Competitive Strengths & Weaknesses
Table 55. Baxter Basic Information, Area Served and Competitors
Table 56. Baxter Major Business
Table 57. Baxter Salivary Gland Cancer Treatment Product and Services
Table 58. Baxter Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Baxter Recent Developments/Updates
Table 60. Baxter Competitive Strengths & Weaknesses
Table 61. Sanofi-Aventis U.S. LLC Basic Information, Area Served and Competitors
Table 62. Sanofi-Aventis U.S. LLC Major Business
Table 63. Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Product and Services
Table 64. Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Sanofi-Aventis U.S. LLC Recent Developments/Updates
Table 66. Sanofi-Aventis U.S. LLC Competitive Strengths & Weaknesses
Table 67. Pierre Fabre Basic Information, Area Served and Competitors
Table 68. Pierre Fabre Major Business
Table 69. Pierre Fabre Salivary Gland Cancer Treatment Product and Services
Table 70. Pierre Fabre Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Pierre Fabre Recent Developments/Updates
Table 72. Pierre Fabre Competitive Strengths & Weaknesses
Table 73. Antares Pharma, Inc Basic Information, Area Served and Competitors
Table 74. Antares Pharma, Inc Major Business
Table 75. Antares Pharma, Inc Salivary Gland Cancer Treatment Product and Services
Table 76. Antares Pharma, Inc Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Antares Pharma, Inc Recent Developments/Updates
Table 78. Antares Pharma, Inc Competitive Strengths & Weaknesses
Table 79. CMS Group Basic Information, Area Served and Competitors
Table 80. CMS Group Major Business
Table 81. CMS Group Salivary Gland Cancer Treatment Product and Services
Table 82. CMS Group Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. CMS Group Recent Developments/Updates
Table 84. Sandoz Inc Basic Information, Area Served and Competitors
Table 85. Sandoz Inc Major Business
Table 86. Sandoz Inc Salivary Gland Cancer Treatment Product and Services
Table 87. Sandoz Inc Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 88. Salivary Gland Cancer Treatment Raw Material
Table 89. Key Manufacturers of Salivary Gland Cancer Treatment Raw Materials
Table 90. Salivary Gland Cancer Treatment Typical Distributors
Table 91. Salivary Gland Cancer Treatment Typical Customers
Table 1. World Salivary Gland Cancer Treatment Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Salivary Gland Cancer Treatment Market Size by Region (2017-2022) & (USD Million)
Table 3. World Salivary Gland Cancer Treatment Market Size by Region (2023-2028) & (USD Million)
Table 4. World Salivary Gland Cancer Treatment Market Size Market Share by Region (2017-2022)
Table 5. World Salivary Gland Cancer Treatment Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Salivary Gland Cancer Treatment Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Salivary Gland Cancer Treatment Players in 2021
Table 9. World Salivary Gland Cancer Treatment Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Salivary Gland Cancer Treatment Company Evaluation Quadrant
Table 11. Head Office of Key Salivary Gland Cancer Treatment Player
Table 12. Salivary Gland Cancer Treatment Market: Company Product Type Footprint
Table 13. Salivary Gland Cancer Treatment Market: Company Product Application Footprint
Table 14. Salivary Gland Cancer Treatment Mergers & Acquisitions Activity
Table 15. United States VS China Salivary Gland Cancer Treatment Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Salivary Gland Cancer Treatment in United States, Headquarters (States, Country)
Table 17. United States Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Salivary Gland Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Salivary Gland Cancer Treatment in China, Company Headquarters (Province, Country)
Table 20. China Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Salivary Gland Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Salivary Gland Cancer Treatment in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Salivary Gland Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Salivary Gland Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Salivary Gland Cancer Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Salivary Gland Cancer Treatment Revenue by Type (2017-2022) & (USD Million)
Table 27. World Salivary Gland Cancer Treatment Revenue by Type (2023-2028) & (USD Million)
Table 28. World Salivary Gland Cancer Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Salivary Gland Cancer Treatment Revenue by Application (2017-2022) & (USD Million)
Table 30. World Salivary Gland Cancer Treatment Revenue by Application (2023-2028) & (USD Million)
Table 31. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 32. Bristol Myers Squibb Major Business
Table 33. Bristol Myers Squibb Salivary Gland Cancer Treatment Product and Services
Table 34. Bristol Myers Squibb Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Bristol Myers Squibb Recent Developments/Updates
Table 36. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 37. LGM Pharma, LLC Basic Information, Area Served and Competitors
Table 38. LGM Pharma, LLC Major Business
Table 39. LGM Pharma, LLC Salivary Gland Cancer Treatment Product and Services
Table 40. LGM Pharma, LLC Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. LGM Pharma, LLC Recent Developments/Updates
Table 42. LGM Pharma, LLC Competitive Strengths & Weaknesses
Table 43. Pfizer Basic Information, Area Served and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Salivary Gland Cancer Treatment Product and Services
Table 46. Pfizer Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Pfizer Recent Developments/Updates
Table 48. Pfizer Competitive Strengths & Weaknesses
Table 49. Bedford Laboratories Basic Information, Area Served and Competitors
Table 50. Bedford Laboratories Major Business
Table 51. Bedford Laboratories Salivary Gland Cancer Treatment Product and Services
Table 52. Bedford Laboratories Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Bedford Laboratories Recent Developments/Updates
Table 54. Bedford Laboratories Competitive Strengths & Weaknesses
Table 55. Baxter Basic Information, Area Served and Competitors
Table 56. Baxter Major Business
Table 57. Baxter Salivary Gland Cancer Treatment Product and Services
Table 58. Baxter Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Baxter Recent Developments/Updates
Table 60. Baxter Competitive Strengths & Weaknesses
Table 61. Sanofi-Aventis U.S. LLC Basic Information, Area Served and Competitors
Table 62. Sanofi-Aventis U.S. LLC Major Business
Table 63. Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Product and Services
Table 64. Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Sanofi-Aventis U.S. LLC Recent Developments/Updates
Table 66. Sanofi-Aventis U.S. LLC Competitive Strengths & Weaknesses
Table 67. Pierre Fabre Basic Information, Area Served and Competitors
Table 68. Pierre Fabre Major Business
Table 69. Pierre Fabre Salivary Gland Cancer Treatment Product and Services
Table 70. Pierre Fabre Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Pierre Fabre Recent Developments/Updates
Table 72. Pierre Fabre Competitive Strengths & Weaknesses
Table 73. Antares Pharma, Inc Basic Information, Area Served and Competitors
Table 74. Antares Pharma, Inc Major Business
Table 75. Antares Pharma, Inc Salivary Gland Cancer Treatment Product and Services
Table 76. Antares Pharma, Inc Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Antares Pharma, Inc Recent Developments/Updates
Table 78. Antares Pharma, Inc Competitive Strengths & Weaknesses
Table 79. CMS Group Basic Information, Area Served and Competitors
Table 80. CMS Group Major Business
Table 81. CMS Group Salivary Gland Cancer Treatment Product and Services
Table 82. CMS Group Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. CMS Group Recent Developments/Updates
Table 84. Sandoz Inc Basic Information, Area Served and Competitors
Table 85. Sandoz Inc Major Business
Table 86. Sandoz Inc Salivary Gland Cancer Treatment Product and Services
Table 87. Sandoz Inc Salivary Gland Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 88. Salivary Gland Cancer Treatment Raw Material
Table 89. Key Manufacturers of Salivary Gland Cancer Treatment Raw Materials
Table 90. Salivary Gland Cancer Treatment Typical Distributors
Table 91. Salivary Gland Cancer Treatment Typical Customers
LIST OF FIGURES
Figure 1. Salivary Gland Cancer Treatment Picture
Figure 2. World Salivary Gland Cancer Treatment Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Salivary Gland Cancer Treatment Total Market Size (2017-2028) & (USD Million)
Figure 4. World Salivary Gland Cancer Treatment Market Size Market Share by Region (2017-2028)
Figure 5. United States Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 6. China Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 7. Europe Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 8. Japan Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 11. India Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 12. Salivary Gland Cancer Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Salivary Gland Cancer Treatment by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Salivary Gland Cancer Treatment Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Salivary Gland Cancer Treatment Markets in 2021
Figure 17. United States VS China: Salivary Gland Cancer Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Salivary Gland Cancer Treatment Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Salivary Gland Cancer Treatment Market Size Market Share by Type in 2021
Figure 20. Surgical Removal
Figure 21. Radiation Therapy
Figure 22. Drug Therapy
Figure 23. Others
Figure 24. World Salivary Gland Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 25. World Salivary Gland Cancer Treatment Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Salivary Gland Cancer Treatment Market Size Market Share by Application in 2021
Figure 27. Hospitals
Figure 28. Clinics
Figure 29. Outpatient Surgery Center
Figure 30. Diagnostic Center
Figure 31. Others
Figure 32. World Salivary Gland Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Salivary Gland Cancer Treatment in 2021
Figure 34. Manufacturing Process Analysis of Salivary Gland Cancer Treatment
Figure 35. Salivary Gland Cancer Treatment Industrial Chain
Figure 36. Distribution Channel Breakdown for Salivary Gland Cancer Treatment Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Salivary Gland Cancer Treatment Picture
Figure 2. World Salivary Gland Cancer Treatment Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Salivary Gland Cancer Treatment Total Market Size (2017-2028) & (USD Million)
Figure 4. World Salivary Gland Cancer Treatment Market Size Market Share by Region (2017-2028)
Figure 5. United States Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 6. China Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 7. Europe Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 8. Japan Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 11. India Salivary Gland Cancer Treatment Market Size (2017-2028) & (USD Million)
Figure 12. Salivary Gland Cancer Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Salivary Gland Cancer Treatment by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Salivary Gland Cancer Treatment Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Salivary Gland Cancer Treatment Markets in 2021
Figure 17. United States VS China: Salivary Gland Cancer Treatment Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Salivary Gland Cancer Treatment Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Salivary Gland Cancer Treatment Market Size Market Share by Type in 2021
Figure 20. Surgical Removal
Figure 21. Radiation Therapy
Figure 22. Drug Therapy
Figure 23. Others
Figure 24. World Salivary Gland Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 25. World Salivary Gland Cancer Treatment Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Salivary Gland Cancer Treatment Market Size Market Share by Application in 2021
Figure 27. Hospitals
Figure 28. Clinics
Figure 29. Outpatient Surgery Center
Figure 30. Diagnostic Center
Figure 31. Others
Figure 32. World Salivary Gland Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Salivary Gland Cancer Treatment in 2021
Figure 34. Manufacturing Process Analysis of Salivary Gland Cancer Treatment
Figure 35. Salivary Gland Cancer Treatment Industrial Chain
Figure 36. Distribution Channel Breakdown for Salivary Gland Cancer Treatment Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
